Carlyle Group

// WOWL ASSESSMENT

Carlyle Group deploys private equity discipline into late-stage venture with catastrophic results — five of six tracked investments are walking dead. The firm writes $100M+ checks into overvalued category leaders past their growth inflection, then lacks the operational toolkit to manufacture exits. Proteus Digital Health filed for bankruptcy after $500M raised, Woowa Brothers trades at fraction of Carlyle's entry price, One Medical sold to Amazon at 50% markdown from peak valuation.

66.7% miss rate reveals fundamental venture-PE translation failure. Proteus Digital Health — the poster child for Carlyle's pattern — raised over $500M to build sensor-laden pills, filed for bankruptcy when FDA approval timelines and reimbursement reality destroyed the business model. One Medical exited to Amazon at steep discount after years of cash burn. Woowa Brothers and VerSe Innovation remain trapped at inflated private marks while cash runs low. Only Delhivery achieved IPO, now trading 60% below Carlyle's entry valuation.

// THREAT LEVEL: ZOMBIECORN

VERDICT: PE megafund discovered venture investing is not private equity with smaller companies — it is different risk, different timelines, different expertise.